31 completed, 15 unknown, 9 terminated, 7 recruiting. 18 Phase 2, 17 Not applicable, 10 Phase 3, 9 Phase 1, 8 Phase 4.
Follow Enteritis: new trials by email Literature Review of Enteritis trials Research Report on Enteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery 5-ASA, Placebo - Ulcerative Colitis (UC), Pouchitis | Phase 4 | Not yet recruiting | University Hospital, Linkoeping | 110 | 2027-04-01 | 2026-08-19 |
| Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC) MTB-targeted phage therapy - Pouchitis, UC - Ulcerative Colitis | Early Phase 1 | Not yet recruiting | Jinling Hospital, China | 12 | 2027-01-01 | 2026-10-22 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Etrasimod as Prevention of Pouchitis etrasimod, Placebo - Pouchitis | Phase 2 | Recruiting | Maia Kayal | 40 | 2026-07-01 | 2026-09-21 |
| CLF065 for Chronic Pouchitis CLF065, Placebo - Pouchitis | Phase 2 | Suspended | Calibr, a division of Scripps Research | 20 | 2026-06-01 | 2026-07-09 |
| GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis Guselkumab, Diet - Pouchitis | Phase 4 | Recruiting | Universitaire Ziekenhuizen KU Leuven | 20 | 2026-04-23 | 2026-05-05 |
| Implementation of a Pain Management Plan in Major Open Abdominal Surgeries. Epidural administered opioid - Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H) | Not applicable | Recruiting | National and Kapodistrian University of Athens | 58 | 2025-11-22 | 2026-10-30 |
| Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch Mirikizumab - Intravenous (IV), Mirikizumab - Subcutaneous (SC) - Pouchitis, Pouches, Ileoanal | Phase 4 | Active not recruiting | University of North Carolina, Chapel Hill | 25 | 2025-08-12 | 2026-10-29 |
| Exploring the Influence of Trptophan on the Treatment of Pouchitis Tryptophan 25mg/kg bodyweight, Placebo - Pouchitis | Not applicable | Not yet recruiting | Universitätsklinikum Hamburg-Eppendorf | 20 | 2025-04-01 | 2025-03-06 |
| A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis Vedolizumab, Concomitant Antibiotic Therapy - Pouchitis | Phase 3 | Recruiting | Takeda | 30 | 2024-11-19 | 2026-08-03 |
| Fecal Microbiota Transplant for Patients With Chronic Pouchitis Fecal Microbiota Transplant (FMT) - Chronic Pouchitis, Pouchitis | Early Phase 1 | Recruiting | Maia Kayal | 16 | 2024-10-03 | 2026-08-17 |
| Rifaximin for the Secondary Prevention of Recurrent Pouchitis Rifaximin 550 MG Oral Tablet [XIFAXAN] - Pouchitis | Phase 4 | Recruiting | University of North Carolina, Chapel Hill | 16 | 2024-07-01 | 2026-10-23 |
| Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis Intestinal Ultrasound - Ulcerative Colitis, Pouchitis | Not applicable | Completed | Mayo Clinic | 66 | 2024-07-01 | 2026-08-12 |
| Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) EXE-346, Placebo - Ileal Pouch | Phase 1 / Phase 2 | Recruiting | Exegi Pharma, LLC | 50 | 2023-11-06 | 2026-05-28 |
| Stem Cells for the Treatment of Pouchitis Mesenchymal Stem Cells (MSCs) - Pouchitis, Crohn's Disease | Phase 1 | Withdrawn | The Cleveland Clinic | 2022-04-01 | 2026-04-16 | |
| Efficacy of Liraglutide Therapy in Patients With IPAA Liraglutide Pen Injector, Placebo Pen Injector - Pouchitis, Irritable Pouch Syndrome | Phase 2 | Terminated | University of North Carolina, Chapel Hill | 8 | 2022-03-22 | 2024-07-23 |
| Assessment of Patients With Acute Pouchitis Treated With Antibiotics Observational, No intervention - Pouchitis, Ulcerative Colitis | Suspended | Alimentiv Inc. | 43 | 2021-12-07 | 2024-02-20 | |
| GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery GM-CSF, fosfomycin and metronidazole - Pouchitis | Phase 1 / Phase 2 | Unknown | Zealand University Hospital | 18 | 2021-09-06 | 2023-01-26 |
| Oral Probiotics on Radiation Enteritis Stage Ⅱ Induced by Pelvic Concurrent Chemoradiotherapy probiotics - Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy | Not applicable | Unknown | Jiangxi Provincial Cancer Hospital | 40 | 2021-08-27 | 2021-09-02 |
| Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy Eupatilin, Rebamipide - Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Unknown | Seoul National University Boramae Hospital | 50 | 2021-06-01 | 2021-05-13 |
Showing 20 of 72. Sign in to see all of them.
Pouchitis (50) · Colitis, Ulcerative (23) · Crohn Disease (10) · Inflammatory Bowel Diseases (6) · Diarrhea (4) · Ileitis (4) · Escherichia coli Infections (3) · Neoplasms (3) · Abdominal Pain (2) · Adenomatous Polyposis Coli (2) · Anastomotic Leak (2) · Colitis (2) · Colorectal Neoplasms (2) · Duodenitis (2)
Digestive System Diseases (72) · Gastroenteritis (72) · Gastrointestinal Diseases (72) · Intestinal Diseases (71) · Ileal Diseases (53) · Ileitis (49) · Colonic Diseases (25) · Colitis (22) · Inflammatory Bowel Diseases (20) · Pathological Conditions, Signs and Symptoms (10) · Infections (7) · Signs and Symptoms (7) · Bacterial Infections (6) · Bacterial Infections and Mycoses (6)
Fecal Microbiota Transplantation (6) · AST 120 (2) · Diet (2) · Hyperbaric Oxygenation (2) · Probiotics (2) · vedolizumab (2) · Adalimumab (1) · Analgesics, Opioid (1) · Ciprofloxacin (1) · Clotrimazole (1) · FODMAP Diet (1) · Fentanyl (1) · Food, Formulated (1) · Fosfomycin (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1)
University of North Carolina, Chapel Hill (4) · Tel-Aviv Sourasky Medical Center (3) · Charite University, Berlin, Germany (2) · Jinling Hospital, China (2) · Johns Hopkins Bloomberg School of Public Health (2) · Maia Kayal (2) · Mayo Clinic (2) · Ocera Therapeutics (2) · Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery (2) · Sahlgrenska University Hospital (2) · Takeda (2) · Universitaire Ziekenhuizen KU Leuven (2) · Aalborg University Hospital (1) · Alimentiv Inc. (1) · Applied Molecular Transport (1)
United States (32) · Belgium (7) · Canada (7) · Israel (6) · Netherlands (6) · Denmark (5) · France (5) · Germany (5) · China (4) · Italy (4) · Spain (4) · United Kingdom (4) · Sweden (3) · Australia (2) · Finland (2)
Ole Thorlacius-Ussing, Professor (3) · Edward Barnes, MD, MPH (2) · Hans Herfarth, MD, PhD (2) · A. Masclee, Prof MD PhD (1) · Alastair Forbes, BSc MD FRCP ILTM (1) · Amy L Lightner, MD (1) · Antonio Di Sabatino, MD (1) · Bo Shen, M.D. (1) · Bo Shen, MD (1) · Carl Brown (1) · Chien-Chang Chen, MD (1) · Chris Dunk (1) · Chunling Jiang, MD,PHD (1)
PMID 19415309, PMID 20135748, PMID 21549404, PMID 21601883, PMID 21983950, PMID 23872668, PMID 24200199, PMID 25110406, PMID 28778448, PMID 32493442, PMID 33501942, PMID 36171082, PMID 36988594, PMID 38668926, PMID 38708959, PMID 38750870, PMID 39025255, PMID 39485259, PMID 39536721, PMID 40856818, PMID 42232317, PMID 42728546
2015 (1), 2023 (1), 2025 (1), R03DK067275 (1), R03DK140415 (1), R43CA141968 (1)